<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.3.450">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Cardiovascular autonomic dysfunction impact on cardiovascular complications across glucose metabolism - 6&nbsp; Materials and methods</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for citations */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging-indent div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./5-results.html" rel="next">
<link href="./3-aim_hypothesis.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>


</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav">
    <div class="container-fluid d-flex">
      <button type="button" class="quarto-btn-toggle btn" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
        <i class="bi bi-layout-text-sidebar-reverse"></i>
      </button>
      <nav class="quarto-page-breadcrumbs" aria-label="breadcrumb"><ol class="breadcrumb"><li class="breadcrumb-item"><a href="./4-methods.html"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Materials and methods</span></a></li></ol></nav>
      <a class="flex-grow-1" role="button" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">      
      </a>
      <button type="button" class="btn quarto-search-button" aria-label="" onclick="window.quartoOpenSearch();">
        <i class="bi bi-search"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse collapse-horizontal sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Cardiovascular autonomic dysfunction impact on cardiovascular complications across glucose metabolism</a> 
    </div>
      </div>
        <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
        </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">This section will not be numbered</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./pdf1-supervisors.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Supervisors and assessment committee</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-disclosure.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Financial support{.unnumbered}</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-preface.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Preface</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./acknowledgements.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Acknowledgements</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-papers.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Papers in the dissertation</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./blank-page.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">{.unnumbered}</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-abbreviations.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Abbreviations</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./1-introduction.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Introduction</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./2-background.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Background</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./3-aim_hypothesis.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Aim and hypothesis</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./4-methods.html" class="sidebar-item-text sidebar-link active">
 <span class="menu-text"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Materials and methods</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./5-results.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Results</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./6-discussion.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Discussion</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./7-perspectives.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Perspective</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./8-conclusion.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">Conclusion</span></span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">References</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./0-abstract.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text">Summary</span></a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">
 <span class="menu-text">Appendices</span></a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true" aria-label="Toggle section">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./app1-resources.html" class="sidebar-item-text sidebar-link">
 <span class="menu-text"><span class="chapter-number">A</span>&nbsp; <span class="chapter-title">Appendix</span></span></a>
  </div>
</li>
      </ul>
  </li>
    </ul>
    </div>
</nav>
<div id="quarto-sidebar-glass" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar,#quarto-sidebar-glass"></div>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#overview-of-the-studies" id="toc-overview-of-the-studies" class="nav-link active" data-scroll-target="#overview-of-the-studies"><span class="header-section-number">6.1</span> Overview of the studies</a></li>
  <li><a href="#study-population" id="toc-study-population" class="nav-link" data-scroll-target="#study-population"><span class="header-section-number">6.1.1</span> Study population</a></li>
  <li><a href="#study-variables" id="toc-study-variables" class="nav-link" data-scroll-target="#study-variables"><span class="header-section-number">6.2</span> Study variables</a>
  <ul class="collapse">
  <li><a href="#measures-for-autonomic-dysfunction-neuropathy" id="toc-measures-for-autonomic-dysfunction-neuropathy" class="nav-link" data-scroll-target="#measures-for-autonomic-dysfunction-neuropathy"><span class="header-section-number">6.2.1</span> Measures for autonomic dysfunction/ neuropathy</a></li>
  <li><a href="#confounders-and-variables-for-instrumental-bias" id="toc-confounders-and-variables-for-instrumental-bias" class="nav-link" data-scroll-target="#confounders-and-variables-for-instrumental-bias"><span class="header-section-number">6.2.2</span> Confounders and variables for instrumental bias</a></li>
  </ul></li>
  <li><a href="#outcomes" id="toc-outcomes" class="nav-link" data-scroll-target="#outcomes"><span class="header-section-number">6.3</span> Outcomes</a>
  <ul class="collapse">
  <li><a href="#arterial-stiffness" id="toc-arterial-stiffness" class="nav-link" data-scroll-target="#arterial-stiffness"><span class="header-section-number">6.3.1</span> Arterial stiffness</a></li>
  <li><a href="#indicators-of-heart-failure" id="toc-indicators-of-heart-failure" class="nav-link" data-scroll-target="#indicators-of-heart-failure"><span class="header-section-number">6.3.2</span> Indicators of heart failure</a></li>
  <li><a href="#cardiovascular-events" id="toc-cardiovascular-events" class="nav-link" data-scroll-target="#cardiovascular-events"><span class="header-section-number">6.3.3</span> Cardiovascular events</a></li>
  </ul></li>
  <li><a href="#statistical-methods" id="toc-statistical-methods" class="nav-link" data-scroll-target="#statistical-methods"><span class="header-section-number">6.4</span> Statistical Methods</a>
  <ul class="collapse">
  <li><a href="#cross-sectional-analysis" id="toc-cross-sectional-analysis" class="nav-link" data-scroll-target="#cross-sectional-analysis"><span class="header-section-number">6.4.1</span> Cross-sectional analysis</a></li>
  <li><a href="#time-to-event-analysis" id="toc-time-to-event-analysis" class="nav-link" data-scroll-target="#time-to-event-analysis"><span class="header-section-number">6.4.2</span> Time-to-event analysis</a></li>
  <li><a href="#effect-modification" id="toc-effect-modification" class="nav-link" data-scroll-target="#effect-modification"><span class="header-section-number">6.4.3</span> Effect modification</a></li>
  <li><a href="#multiple-imputed-by-chained-equations" id="toc-multiple-imputed-by-chained-equations" class="nav-link" data-scroll-target="#multiple-imputed-by-chained-equations"><span class="header-section-number">6.4.4</span> Multiple imputed by chained equations</a></li>
  <li><a href="#instrumental-bias" id="toc-instrumental-bias" class="nav-link" data-scroll-target="#instrumental-bias"><span class="header-section-number">6.4.5</span> Instrumental bias</a></li>
  </ul></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Materials and methods</span></h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  

</header>

<section id="overview-of-the-studies" class="level2 landscape" data-number="6.1">
<h2 data-number="6.1" class="anchored" data-anchor-id="overview-of-the-studies"><span class="header-section-number">6.1</span> Overview of the studies</h2>
<table class="table">
<caption>Overview of studies</caption>
<colgroup>
<col style="width: 19%">
<col style="width: 27%">
<col style="width: 27%">
<col style="width: 27%">
</colgroup>
<thead>
<tr class="header">
<th></th>
<th>Study I</th>
<th>Study II</th>
<th>Study III</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Title</td>
<td>Cardiovascular autonomic dysfunction is linked with arterial stiffness across glucose metabolism: The Maastricht Study</td>
<td>Cardiovascular autonomic dysfunction precedes cardiovascular disease and all-cause mortality: 11-year follow-up in the ADDITION-PRO study</td>
<td>Cardiovascular autonomic neuropathy and indices of heart failure in type 2 diabetes: The CANCAN Study</td>
</tr>
<tr class="even">
<td>Design</td>
<td>Aetiological cross-sectional study</td>
<td>Aetiological prospective cohort study</td>
<td>Descriptive cross-sectional study</td>
</tr>
<tr class="odd">
<td>Cohort</td>
<td>The Maastricht Study</td>
<td>ADDITION-PRO study</td>
<td>CANCAN study</td>
</tr>
<tr class="even">
<td>Study population</td>
<td>3673 individuals with NGM, prediabetes, or T2D</td>
<td>2082 individuals with high risk of diabetes</td>
<td>176 patients with T2D visiting outpatients clinics</td>
</tr>
<tr class="odd">
<td>Data sources</td>
<td>Observational phenotyping cohort of type 2 diabetes in the Netherlands</td>
<td>Cohort study of selected individuals based on having high risk of diabetes</td>
<td>Clinical cohort study</td>
</tr>
<tr class="even">
<td>Determinant</td>
<td>24-hour HRV</td>
<td>Multiday and hourly HRV</td>
<td>Cardiovascular autonomic reflex test</td>
</tr>
<tr class="odd">
<td>Primary outcome</td>
<td>Arterial stiffness</td>
<td>Major adverse cardiovascular events, heart failure, and all-cause mortality</td>
<td>NT-proBNP, NYHA classification, and WATCH-DM risk score</td>
</tr>
<tr class="even">
<td>Statistical analysis</td>
<td>Linear regression</td>
<td>Poisson regression</td>
<td>Logistic regression</td>
</tr>
<tr class="odd">
<td>Missing data</td>
<td>Complete case analysis</td>
<td>Multiple imputation of chained equations for confounders</td>
<td>Complete case analysis and multiple imputation of chained equations for CART and confounders</td>
</tr>
</tbody>
</table>
</section>
<section id="study-population" class="level3" data-number="6.1.1">
<h3 data-number="6.1.1" class="anchored" data-anchor-id="study-population"><span class="header-section-number">6.1.1</span> Study population</h3>
<div class="center">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><embed src="images/cohort_map.pdf" class="img-fluid" style="width:8in"></p>
<figcaption class="figure-caption"><strong>Map of Study populations</strong></figcaption>
</figure>
</div>
</div>
<section id="study-i---the-maastricht-study" class="level4" data-number="6.1.1.1">
<h4 data-number="6.1.1.1" class="anchored" data-anchor-id="study-i---the-maastricht-study"><span class="header-section-number">6.1.1.1</span> Study I - The Maastricht Study</h4>
<p>The Maastricht Study is a prospective, observational phenotyping study in the province of Limburg, located in the southern part of the Netherlands. The recruitment of individuals with T2D was emphasized through the regional Diabetes Patient Registry, with the aim of extensively phenotyping individuals with T2D and those in intermediate stages of the disease. Eligibility criteria included an age range of 40–70 years. Participants were recruited through mass media campaigns and mailings from municipal registries (Gemeentelijke Basis Administratie; GBA).<span class="citation" data-cites="schram2014"><sup><a href="references.html#ref-schram2014" role="doc-biblioref">1</a></sup></span> In the analysis of Study I, the study among 7449 individuals included participants with measurements of 24-hour HRV and at least one measure of arterial stiffness (carotid-femoral pulse wave velocity or carotid artery distensibility), both of which were completed within a three-month period between November 2010 and December 2020. Among those participants with prior CVD were excluded<span class="citation" data-cites="schaarup2024"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a></sup></span>. Approval was granted by the institutional medical ethics committee (NL31329.068.10) and the Minister of Health, Welfare and Sports of the Netherlands (Permit 131088-105234-PG). Written informed consent was given by all participants.<span class="citation" data-cites="schaarup2024"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a></sup></span></p>
</section>
<section id="study-ii---addition-pro" class="level4" data-number="6.1.1.2">
<h4 data-number="6.1.1.2" class="anchored" data-anchor-id="study-ii---addition-pro"><span class="header-section-number">6.1.1.2</span> Study II - ADDITION-PRO</h4>
<p>The ADDITION-PRO study is a prospective, population-based cohort nested within the Danish arm of the ADDITION-Europe study. ADDITION was originally designed as a stepwise screening program for T2D in general practice, with the aim of identifying individuals with screen-detected T2D for recruitment into the ADDITION trial. The objective of ADDITION-PRO is to investigate early markers of CVD and metabolic dysfunction in individuals in different tiers of diabetes risk.</p>
<p>The ADDITION-Europe screening program identified a large number of individuals with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and normoglycemia despite having risk factors for diabetes and CVD. Participants for ADDITION-PRO were recruited from the original ADDITION-DK screening cohort, which included individuals from 190 general practices across Denmark. The recruitment strategy focused on individuals at high risk of diabetes without T2D, identified through a stepwise screening program that incorporated the Danish diabetes risk score from the Inter99 study<span class="citation" data-cites="christensen2004a"><sup><a href="references.html#ref-christensen2004a" role="doc-biblioref">3</a></sup></span>. This assessment, conducted between 2001 and 2006, considered factors such as age, sex, history of gestational diabetes, family history of diabetes, known hypertension, BMI, and physical activity. High-risk individuals were further screened for T2D using blood measurements, including HbA1c, random blood glucose, FPG, and OGTT. Those with screen-detected diabetes, confirmed by a second OGTT, were invited to participate in the ADDITION trial. High risk individuals without T2D were further considered in as the sampling frame for ADDITION-PRO.</p>
<p>Between 2009 and 2011, a follow-up health examination was conducted at four ADDITION-DK study centers to establish a cohort baseline. Eligible participants were those still alive, residing near the research centers (Steno Diabetes Center Copenhagen, Aarhus University Hospital, Holstebro Hospital, and the Hospital of South West Jutland, Esbjerg), and who had not withdrawn consent. Eligibility criteria included individuals aged 40–70 years who had previously undergone diabetes screening in ADDITION-DK. Exclusion criteria included pregnancy, psychological or psychiatric disorders preventing informed consent, and life-limiting conditions. One key feature of the data collection was the precise measurement of physical activity and energy expenditure using a combined chest-worn accelerometer/heart rate monitor (ActiHeart), which recorded acceleration and heart rate over a week. In Study II, participants with at least a 48-hour recording were included for the primary analysis, and then participants with hourly measures of physical acceleration during the hourly HRV recording were included in the second analysis. Participants with prior CVD ten years before inclusion were also excluded.</p>
<p>Disease history and follow-up data for the population were obtained from Denmark’s national registry system, which allows linkage of health records using the personal Civil Registration Number assigned to all citizens. The following national registries were accessed to collect information on incident CVD and mortality, medication use, and healthcare utilization: the National Patient Registry (hospital admissions and outpatient contacts), the National Health Service Registry (general practice visits), the Medical Prescription Registry, the Diabetes Registry, and the Cause of Death Registry.</p>
</section>
<section id="study-iii---cancan" class="level4" data-number="6.1.1.3">
<h4 data-number="6.1.1.3" class="anchored" data-anchor-id="study-iii---cancan"><span class="header-section-number">6.1.1.3</span> Study III - CANCAN</h4>
<p>The CANCAN Study is an observational study conducted at two hospital outpatient clinics: Viborg Regional Hospital and Regional Hospital Gødstrup. The aim is to implement a screening protocol for identifying high-risk individuals using CAN assessments, continuous glucose monitoring, and heart failure indicators. All measures were part of routine clinical care for T2D in Central Denmark. A total of 200 adults (&gt;18 years) with T2D and a disease duration of over one year were included. Exclusion criteria were recent laser-treated eye disease (≤3 months), pregnancy, lactation, life-threatening illness, or cognitive impairment preventing consent. Participants were identified via electronic records and were informed about the study by their doctor during a telephone call. Those interested were invited to attend a dedicated meeting before their annual diabetes exam, during which study details were discussed. Recruitment was conducted from 2021 to 2024. In Study III, participants without a valid NT-proBNP measurement were excluded.</p>
</section>
</section>
<section id="study-variables" class="level2" data-number="6.2">
<h2 data-number="6.2" class="anchored" data-anchor-id="study-variables"><span class="header-section-number">6.2</span> Study variables</h2>
<section id="measures-for-autonomic-dysfunction-neuropathy" class="level3" data-number="6.2.1">
<h3 data-number="6.2.1" class="anchored" data-anchor-id="measures-for-autonomic-dysfunction-neuropathy"><span class="header-section-number">6.2.1</span> Measures for autonomic dysfunction/ neuropathy</h3>
<div id="fig-monitor" class="quarto-figure quarto-figure-center anchored">
<figure class="figure">
<p><embed src="images/can_tools.pdf" class="img-fluid"> <em>Left: Holter monitor; Middle: Actiheart; Right: Vagus™ device</em></p>
<figcaption class="figure-caption">Figure&nbsp;6.1: <strong>Heart rate monitors</strong></figcaption>
</figure>
</div>
<p><strong>Heart rate variability</strong></p>
<p>In Studies I–III, different devices were used to capture the distance between each heartbeat, defined as RR intervals, from electrocardiogram traces—either directly from heartbeat traces or indirectly from pulse traces. From these, a sequence of successive heartbeat intervals was extracted to calculate time- and frequency-domain HRV.</p>
<div id="fig-hrv" class="quarto-figure quarto-figure-center anchored">
<figure class="figure">
<p><embed src="images/measurements_hrv.pdf" class="img-fluid"> <em>Time- and Frequency domain HRV indices (Source: Author)</em></p>
<figcaption class="figure-caption">Figure&nbsp;6.2: <strong>Heart rate variability calculations</strong></figcaption>
</figure>
</div>
<p><em>Time-domain indices</em></p>
<p>Time-domain measures of HRV are based on the statistical distribution of normal-to-normal (NN) heartbeat intervals. Descriptions of time-domain indices are summarized in <a href="#tbl-td">Table&nbsp;<span>6.1</span></a>.</p>
<div id="tbl-td" class="anchored">
<table class="table">
<caption>Table&nbsp;6.1: Time-domain indices reflections of autonomic function</caption>
<colgroup>
<col style="width: 40%">
<col style="width: 60%">
</colgroup>
<thead>
<tr class="header">
<th>Time-domain HRV</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Standard deviation of NN heart beat intervals (SDNN, in ms)</strong></td>
<td>Measures the total variation in interbeat intervals and reflects both sympathetic and parasympathetic activity<span class="citation" data-cites="taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996"><sup><a href="references.html#ref-taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996" role="doc-biblioref">4</a></sup></span>.</td>
</tr>
<tr class="even">
<td><strong>SD of the averages of NN intervals in 5-minute segments throughout the recording (SDANN, in ms)</strong></td>
<td>Measures variations in 5-minute mean interbeat intervals, primarily reflecting autonomic fluctuations associated with the circadian rhythm<span class="citation" data-cites="taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996"><sup><a href="references.html#ref-taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996" role="doc-biblioref">4</a></sup></span></td>
</tr>
<tr class="odd">
<td><strong>Mean of the SDs of all NN intervals for all 5-minute segments (SDNN index, in ms)</strong></td>
<td>Measures the average short-term variability in interbeat intervals across successive 5-minute periods, reflecting both sympathetic and parasympathetic modulation of heart rate<span class="citation" data-cites="taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996"><sup><a href="references.html#ref-taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996" role="doc-biblioref">4</a></sup></span></td>
</tr>
<tr class="even">
<td><strong>NN50 count divided by the total number of all NN intervals (pNN50, percentage)</strong></td>
<td>Measures the proportion of successive interbeat intervals differing by more than 50 ms, primarily reflecting parasympathetic (vagal) activity<span class="citation" data-cites="umetani1998"><sup><a href="references.html#ref-umetani1998" role="doc-biblioref">5</a></sup></span>.</td>
</tr>
<tr class="odd">
<td><strong>Square root of the mean of the sum of squares of differences between adjacent NN intervals (RMSSD, in ms)</strong></td>
<td>Measures variation in successive interbeat intervals during inhalation and exhalation, primarily reflecting parasympathetic (vagal) activity<span class="citation" data-cites="umetani1998"><sup><a href="references.html#ref-umetani1998" role="doc-biblioref">5</a></sup></span></td>
</tr>
</tbody>
</table>
</div>
<p><em>Frequency-domain indices</em></p>
<p>Frequency-domain HRV indices are derived from sequences of NN intervals that have been transformed into the spectral domain using Fourier transformation. These indices quantify heart rate oscillations over different timescales. Short-term variations, such as respiratory sinus arrhythmia, are reflective of rapid autonomic changes, while longer oscillations are indicative of autonomic responses to posture changes, circadian rhythms, or other physiological processes. Descriptions of frequency-domain indices are summarized in <a href="#tbl-fq">Table&nbsp;<span>6.2</span></a>. .</p>
<div id="tbl-fq" class="anchored">
<table class="table">
<caption>Table&nbsp;6.2: Frequency-domain indices reflections of autonomic function</caption>
<colgroup>
<col style="width: 40%">
<col style="width: 60%">
</colgroup>
<thead>
<tr class="header">
<th>Frequency domain HRV</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Variance of all NN intervals ≤ 0.4 Hz, total power (TP, in ms²)</strong></td>
<td>Measures the total variation in interbeat intervals, reflecting both short- and long-term autonomic regulation by the sympathetic and parasympathetic nervous system.<span class="citation" data-cites="taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996"><sup><a href="references.html#ref-taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996" role="doc-biblioref">4</a></sup></span></td>
</tr>
<tr class="even">
<td><strong>Ultra low-frequency range (ULF, in ms² ≤ 0.003 Hz)</strong></td>
<td>Measures very long-term oscillations in interbeat intervals, influenced by autonomic responses to circadian rhythms, physical activity, metabolic processes, and thermoregulation.<span class="citation" data-cites="serrador1999 akselrod1981"><sup><a href="references.html#ref-serrador1999" role="doc-biblioref">6</a>,<a href="references.html#ref-akselrod1981" role="doc-biblioref">7</a></sup></span></td>
</tr>
<tr class="odd">
<td><strong>Very-low-frequency range (VLF, in ms²; 0.003–0.04 Hz)</strong></td>
<td>Measures oscillations in interbeat intervals over 5-minute periods, reflecting the activity of the renin–angiotensin system and peaks in sympathetic nervous system activity, while also depending on parasympathetic modulation.<span class="citation" data-cites="taylor1998 jeffreyj.goldberger2019"><sup><a href="references.html#ref-taylor1998" role="doc-biblioref">8</a>,<a href="references.html#ref-jeffreyj.goldberger2019" role="doc-biblioref">9</a></sup></span></td>
</tr>
<tr class="even">
<td><strong>Low-frequency range (LF, in ms²; 0.04–0.15 Hz)</strong></td>
<td>Measures intermediate oscillations in interbeat intervals, reflecting a combination of sympathetic and parasympathetic nervous system activity, particularly associated with baroreflex function and blood pressure regulation.<span class="citation" data-cites="mccraty2015"><sup><a href="references.html#ref-mccraty2015" role="doc-biblioref">10</a></sup></span></td>
</tr>
<tr class="odd">
<td><strong>High-frequency range (HF, in ms²; 0.15–0.4 Hz)</strong></td>
<td>Measures short-term oscillations during inspiration and expiration, reflecting parasympathetic modulation of heart rate via the vagus nerve, and closely associated with respiratory sinus arrhythmia.<span class="citation" data-cites="elghozi1991"><sup><a href="references.html#ref-elghozi1991" role="doc-biblioref">11</a></sup></span></td>
</tr>
</tbody>
</table>
</div>
<p><strong>Holter recordings in study I</strong></p>
<p>All ECG recordings were obtained using a 12-lead Holter system (Fysiologic ECG Services, Amsterdam, the Netherlands) over 24 hours, as previously described.<span class="citation" data-cites="schram2014"><sup><a href="references.html#ref-schram2014" role="doc-biblioref">1</a></sup></span> Participants were instructed to follow their regular daily activities but avoid showering during the recording. The ECG data were processed using proprietary Holter Analysis Software (Fysiologic ECG Services), where artefacts and ectopic beats were excluded through automated processing and manual validation. A minimum recording duration of 18 hours was required for further analysis.<span class="citation" data-cites="schaarup2024 coopmans2020"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a>,<a href="references.html#ref-coopmans2020" role="doc-biblioref">12</a></sup></span> Inter-beat intervals between consecutive sinus beats were provided in milliseconds (ms). Time-domain HRV indices were calculated, including SDNN, SDANN, RMSSD, SDNN index, and pNN50. Frequency-domain measures were derived using Fast Fourier Transform, including TP, ULF, VLF, LF, and HF.<span class="citation" data-cites="schaarup2024"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a></sup></span>Outliers were removed. HRV indices were standardized by their mean and SD, and composite Z-scores were computed for time and frequency-domain measures, respectively. This selection of indices covers the main sources of HRV variance.<span class="citation" data-cites="schaarup2024"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a></sup></span></p>
<p><strong>ActiHeart heart rate and physical activity in study II</strong></p>
<p>Heart rate was measured using a combined accelerometer and heart rate monitor (ActiHeart, CamNTech, Cambridge, UK), which recorded uniaxial acceleration and heart rate. The data collection and processing methods have been described previously. Mean heart rates were recorded in 30-second epochs. Based on an algorithm, distributions of inter-beat intervals were calculated in each 30-second epoch.<span class="citation" data-cites="schaarup2024a"><sup><a href="references.html#ref-schaarup2024a" role="doc-biblioref">13</a></sup></span> HRV calculations were performed using the RHRV package (version 4.2.7) in R.<span class="citation" data-cites="schaarup2024a schaarup2024b"><sup><a href="references.html#ref-schaarup2024a" role="doc-biblioref">13</a>,<a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span> The algorithm was tested on a dataset with full access to all inter-beat intervals.<span class="citation" data-cites="schaarup2024a"><sup><a href="references.html#ref-schaarup2024a" role="doc-biblioref">13</a></sup></span> HRV indices based on global distribution in 24-hour recordings showed high validity.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span> HRV indices including SDNN, SDANN, SDNN index, TINN, and mean heart rate (HR) were calculated by week, 24-hour cycle, and hour of the day, with hourly values averaged across recording days.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span></p>
<p><strong>Vagus device for cardiovascular autonomic reflex test in study III</strong></p>
<p>CAN was diagnosed using cardiovascular autonomic reflex tests (CARTs), the gold standard for CAN assessment. R-R intervals were derived from an ECG signal using the Vagus™ device (Medicus Engineering, Aarhus, Denmark).<span class="citation" data-cites="hansen2025 schaarup2025"><sup><a href="references.html#ref-hansen2025" role="doc-biblioref">15</a>,<a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span> Pulse rate ratios were measured under different conditions.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span> Three standardized cardiovascular autonomic reflex tests (CARTs) were performed: (1) lying-to-standing, (2) deep breathing, and (3) the Valsalva maneuver, following a standardized protocol conducted between 8:00 a.m. and 2:00 p.m., after 10 minutes of supine rest.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span> Smoking and caffeine intake were prohibited two hours before testing. Each test was conducted once by trained examiners.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
<p>Manifest CAN was defined as two or more abnormal CARTs using an age-based formula.<span class="citation" data-cites="hansen2025"><sup><a href="references.html#ref-hansen2025" role="doc-biblioref">15</a></sup></span> The Vagus™ device’s accuracy has been validated against FDA standards and stationary devices, showing moderate to high reproducibility.<span class="citation" data-cites="fleischer2011"><sup><a href="references.html#ref-fleischer2011" role="doc-biblioref">17</a></sup></span> Orthostatic hypotension was defined as a sustained drop in systolic blood pressure of ≥20 mmHg or diastolic blood pressure of ≥10 mmHg within three minutes of standing.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
<div id="fig-cart" class="quarto-figure quarto-figure-center anchored">
<figure class="figure">
<p><img src="images/cart.png" class="img-fluid figure-img" data-fig-align="left"> <em>(source: Author)</em></p>
<figcaption class="figure-caption">Figure&nbsp;6.3: <strong>Cardiovascular autonomic reflex test</strong></figcaption>
</figure>
</div>
</section>
<section id="confounders-and-variables-for-instrumental-bias" class="level3" data-number="6.2.2">
<h3 data-number="6.2.2" class="anchored" data-anchor-id="confounders-and-variables-for-instrumental-bias"><span class="header-section-number">6.2.2</span> Confounders and variables for instrumental bias</h3>
<p>Across Studies I, II, and III, a comprehensive set of covariates and potential confounders was assessed, including lifestyle factors, clinical measurements, biochemical markers, and socioeconomic indicators.<span class="citation" data-cites="schaarup2024 schaarup2024b schaarup2025"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a>,<a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a>,<a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
<p>Smoking status was self-reported in all studies and categorized as never, former, or current (Study I); current/ex/never (Study II); and smoker/non-smoker (Study III). Alcohol consumption was recorded as average weekly units in all three studies.<span class="citation" data-cites="schaarup2024 schaarup2024b schaarup2025"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a>,<a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a>,<a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span> Physical activity was assessed via self-report in Studies I, II, and III. In Study I, total and moderate-to-vigorous activity (hours/week) was recorded. Study II used the Recent Physical Activity Questionnaire (RPAQ) to calculate physical activity energy expenditure (PAEE), while Study III classified activity as sedentary or non-sedentary.<span class="citation" data-cites="schaarup2024 schaarup2024b schaarup2025"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a>,<a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a>,<a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span> Study II also used combined accelerometry and heart rate monitoring (ActiHeart) to estimate PAEE.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span> Register-based data on socioeconomic status at baseline, including education length, income, and employment status, were included in Study II.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span> All studies included measurements of body mass index (BMI), waist circumference, and systolic and diastolic blood pressure, obtained during clinical examinations.<span class="citation" data-cites="schaarup2024 schaarup2024b schaarup2025"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a>,<a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a>,<a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
<p>Blood samples were analyzed in all studies for HbA1c, fasting plasma glucose (FPG), triglycerides, total cholesterol, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol.<span class="citation" data-cites="schaarup2024 schaarup2024b schaarup2025"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a>,<a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a>,<a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span> Study I also included a 2-hour oral glucose tolerance test (OGTT) to classify glucose metabolism status based on FPG and OGTT (normal, prediabetes, T2D) using WHO 2006 criteria, excluding HbA1c as a diagnostic criterion.<span class="citation" data-cites="schaarup2024"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a></sup></span> Additionally, measured creatinine, estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
<p>Self-reported history of CVD and use of anti-hypertensive, glucose-lowering, and lipid-lowering medications were collected in all studies.<span class="citation" data-cites="schaarup2024 schaarup2024b schaarup2025"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a>,<a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a>,<a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span> In Study II, history of CVD events in the 10 years prior to baseline was retrieved from national registers.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span> In Study III, history of CVD was collected through electronic patient records.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
</section>
</section>
<section id="outcomes" class="level2" data-number="6.3">
<h2 data-number="6.3" class="anchored" data-anchor-id="outcomes"><span class="header-section-number">6.3</span> Outcomes</h2>
<section id="arterial-stiffness" class="level3" data-number="6.3.1">
<h3 data-number="6.3.1" class="anchored" data-anchor-id="arterial-stiffness"><span class="header-section-number">6.3.1</span> Arterial stiffness</h3>
<p>Arterial stiffness is characterized by arteriosclerosis and atherosclerosis properties of the arteries. The stiffness of different segments of the vascular musculature can be assessed both locally and dynamically. Aortic and carotid stiffness were assessed as markers of arterial stiffness, following previously described procedures.<span class="citation" data-cites="tanlaizhou2018"><sup><a href="references.html#ref-tanlaizhou2018" role="doc-biblioref">18</a></sup></span></p>
<p><strong>Pulse wave velocity</strong></p>
<p>Aortic stiffness was measured by carotid-femoral pulse wave velocity (cf-PWV) using applanation tonometry (SphygmoCor, Atcor Medical, Sydney, Australia), with the median of at least three consecutive recordings included in the analysis. cf-PWV was calculated based on the time between the ECG systole and the arrival of the pressure wave at the femoral and carotid measurement sites along with the distance between these two measurement sites. cf-PWV was measured with participants in a supine position following a 10-minute rest period. The aortic path length was determined using a tape measure by subtracting the carotid-to-sternal notch distance from the femoral-to-sternal notch distance.<span class="citation" data-cites="tanlaizhou2018"><sup><a href="references.html#ref-tanlaizhou2018" role="doc-biblioref">18</a></sup></span></p>
<p><strong>Carotid artery distensibility</strong></p>
<p>Carotid stiffness was assessed by the carotid artery distensibility coefficient (CD), based on ultrasound imaging of the left common carotid artery using a 7.5 MHz linear probe (MyLab 70, Esaote Europe, Maastricht, the Netherlands). CD was calculated as ΔD/braPP, where ΔD represents carotid distension and braPP is brachial pulse pressure. Mean heart rate and mean arterial pressure (MAP) were recorded every five minutes using an oscillometric device (Accutorr Plus, Datascope, Montvale, NJ, USA).<span class="citation" data-cites="tanlaizhou2018"><sup><a href="references.html#ref-tanlaizhou2018" role="doc-biblioref">18</a></sup></span></p>
<div id="fig-as" class="quarto-figure quarto-figure-center anchored">
<figure class="figure">
<p><embed src="images/Methods_arterial_stiffness.pdf" class="img-fluid"> <em>Measures of arterial stiffness, measured dynamically through the decending aorta and locally ay carotid sites. (Source: Author)</em></p>
<figcaption class="figure-caption">Figure&nbsp;6.4: <strong>Aortic and carotid stiffness</strong></figcaption>
</figure>
</div>
</section>
<section id="indicators-of-heart-failure" class="level3" data-number="6.3.2">
<h3 data-number="6.3.2" class="anchored" data-anchor-id="indicators-of-heart-failure"><span class="header-section-number">6.3.2</span> Indicators of heart failure</h3>
<p>N-terminal prohormone of brain natriuretic peptide (NT-proBNP) is a neuretic peptide that can be used to detect patients with heart failure and the progression of heart failure<span class="citation" data-cites="willeit2016"><sup><a href="references.html#ref-willeit2016" role="doc-biblioref">19</a></sup></span>. It derives from B-type natriuretic peptid (BNP) which is a cardial neurohormone, that is synthesized and secreted as response to stretched cariomycytes and cardiac volume overload. After secretion, proBNP is cleaved, releasing the active hormone BNP along with the remaining N-terminal fragment, known as NT-proBNP<span class="citation" data-cites="willeit2016"><sup><a href="references.html#ref-willeit2016" role="doc-biblioref">19</a></sup></span>. In Study III, a blood sample was taken at the study cite. A description of the NT-proBNP analysis of plasma samples is provided in the supplementary material in Appendix Study III.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
<p>A modified version of the validated WATCH-DM heart failure risk score was used. The risk score is based on nine variables: two binary (history of myocardial infarction and coronary artery bypass grafting) and seven continuous (age, BMI, systolic/diastolic BP, serum creatinine, HDL cholesterol, and HbA1c). Scores range from 0–39 and are categorized as very low (≤11), low (12–13), moderate (14–15), high (16–18), and very high (≥19) risk.<span class="citation" data-cites="schaarup2025 segar2022 segar2019"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a>,<a href="references.html#ref-segar2022" role="doc-biblioref">20</a>,<a href="references.html#ref-segar2019" role="doc-biblioref">21</a></sup></span></p>
<p>NYHA class stage I–IV was included. Heart failure symptoms were defined as NYHA class II–IV, assessed by a physician.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
</section>
<section id="cardiovascular-events" class="level3" data-number="6.3.3">
<h3 data-number="6.3.3" class="anchored" data-anchor-id="cardiovascular-events"><span class="header-section-number">6.3.3</span> Cardiovascular events</h3>
<p>Information on CVD events and mortality was obtained from the Danish National Patient Registers until 2021 by utilizing the ICD-10 codes for stroke, myocardial infarction, cardiovascular death, cardiovascular revascularization, and heart failure. Three-point major adverse cardiovascular events (MACE) was defined as myocardial infarction, stroke, cardiovascular revascularization, and cardiovascular death.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span></p>
<div id="tbl_cvd" class="tbl" data-caption="Diagnosis Codes for CVD endpoints" data-tbl-colwidths="[40, 60]">
<table class="table">
<colgroup>
<col style="width: 22%">
<col style="width: 77%">
</colgroup>
<thead>
<tr class="header">
<th>Outcome</th>
<th>Diagnosis Codes</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Heart failure</strong></td>
<td>ICD: I50</td>
</tr>
<tr class="even">
<td><strong>Three-point MACE</strong></td>
<td><em>(composite outcome)</em></td>
</tr>
<tr class="odd">
<td>- Stroke</td>
<td>ICD: I61–I64</td>
</tr>
<tr class="even">
<td>- Myocardial infarction</td>
<td>ICD: I21–I24</td>
</tr>
<tr class="odd">
<td>- Cardiovascular death</td>
<td>ICD: I20–I28, I42, I46</td>
</tr>
<tr class="even">
<td>- Cardiovascular revascularization</td>
<td>SKA: KPAE10, KPAE25, KPAF10, KPAF20, KPAF21, KPAF22, KPAH10, KPAH20, KPAH21, KPEE, KPEF, KPEH, KPEP, KPEQ, KPFE, KPFH, KPFP, KPFQ</td>
</tr>
</tbody>
</table>
</div>
</section>
</section>
<section id="statistical-methods" class="level2" data-number="6.4">
<h2 data-number="6.4" class="anchored" data-anchor-id="statistical-methods"><span class="header-section-number">6.4</span> Statistical Methods</h2>
<section id="cross-sectional-analysis" class="level3" data-number="6.4.1">
<h3 data-number="6.4.1" class="anchored" data-anchor-id="cross-sectional-analysis"><span class="header-section-number">6.4.1</span> Cross-sectional analysis</h3>
<p><em>Study I</em></p>
<p>In Study I, multiple linear regression was used to investigate associations between 24-hour HRV and arterial stiffness. Model 1 was adjusted for age, sex, education, glucose metabolism status, and mean arterial pressure (MAP) to account for the oversampling of individuals with T2D and potential instrumental bias of arterial pressure flow. Model 2 included additional adjustments for smoking behavior, alcohol consumption, physical activity, BMI, HbA1c, triglycerides, total-to-HDL cholesterol ratio, and medication use. Arterial stiffness measures were log-transformed to ensure normally distributed residuals and were back-transformed into percentage change estimates. A sex interaction term was added to assess whether the association differed by sex. Sensitivity analyses were performed excluding individuals on antihypertensive treatment or glucose-lowering medication.<span class="citation" data-cites="schaarup2024"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a></sup></span></p>
<p><em>Study III</em></p>
<p>In Study III, logistic regression models were applied to investigate the association between CAN and heart failure, using elevated NT-proBNP (concentration &gt;125 pg/ml) as the primary outcome. Adjustments were made for age, sex, diabetes duration, smoking behavior, alcohol consumption, BMI, HbA1c, triglycerides, total cholesterol, antihypertensive medication, eGFR, and prior CVD. Sensitivity analyses were performed excluding participants with beta-blocker treatment or prior CVD. Logistic regression was also applied to assess the odds of CAN being associated with heart failure symptoms, defined as NYHA class II or higher, adjusting for covariates in the primary analysis. Linear regression was employed to evaluate differences in the WATCH-DM risk score between individuals with and without CAN.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
</section>
<section id="time-to-event-analysis" class="level3" data-number="6.4.2">
<h3 data-number="6.4.2" class="anchored" data-anchor-id="time-to-event-analysis"><span class="header-section-number">6.4.2</span> Time-to-event analysis</h3>
<p>In Study II, Poisson regression models were used to quantify the associations between multiday HRV and cardiovascular events, as follow-up data were undisturbed over time and to avoid assumptions of proportional hazards.<span class="citation" data-cites="whoneed2012"><sup><a href="references.html#ref-whoneed2012" role="doc-biblioref">22</a></sup></span> Multiday HRV was modelled using splines with knots at predefined percentiles to assess non-linear associations. Hourly HRV was analysed separately for each hour to observe whether the association of HRV exhibited diurnal variation. Both HRV and mHR were standardized by their mean and standard deviation to ensure comparability. Based on assumptions about potential confounding pathways summarized in directed acyclic graphs (DAGs), two models were fitted: Model 1 adjusted for age and sex, while Model 2 further adjusted for education, smoking, alcohol consumption, physical activity (PAEE calculated from the Recent Physical Activity Questionnaire, RPAQ), body mass index, total cholesterol, and HbA1c. Additional analyses were performed with HRV pre-adjusted for concurrent heart rate and physical acceleration to account for the influence of these factors. Missing covariates were handled using multiple imputation. Each individual’s follow-up period began at the time of their inclusion in the baseline examination.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span></p>
<p>To calculate age-specific incidence rates (IR), follow-up ended at the earliest occurrence of CVD, heart failure, all-cause mortality, or the end of the study period. The follow-up time was divided into one-year intervals based on the individual’s age. Using this age-split data, incidence rates of CVD, heart failure, and all-cause mortality were analysed in relation to HRV, with age treated as a time-varying covariate in a Poisson regression model.</p>
</section>
<section id="effect-modification" class="level3" data-number="6.4.3">
<h3 data-number="6.4.3" class="anchored" data-anchor-id="effect-modification"><span class="header-section-number">6.4.3</span> Effect modification</h3>
<p>Effect modification was assessed to determine whether the association between an exposure and an outcome varied depending on the level of a third variable, known as the effect modifier.<span class="citation" data-cites="knol2012"><sup><a href="references.html#ref-knol2012" role="doc-biblioref">23</a></sup></span></p>
<p>In Study I, it was hypothesized that the association between 24-hour HRV and arterial stiffness was stronger in strata of diabetes progression (normal glucose metabolism, prediabetes, T2D). Therefore, an interaction term between HRV and diabetes status was included to observe the size of the association across strata.<span class="citation" data-cites="schaarup2024"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a></sup></span> A subsidiary analysis was conducted in a subpopulation without T2D to assess whether the effect was modified by HbA1c.</p>
<p>In Study II, the variation in the association between multiday HRV and CVD endpoints by sex was quantified to explore potential biological dimorphism.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span></p>
<p>In Study III, the presence of an association between CAN and elevated NT-proBNP in the subgroup without symptoms (NYHA class &lt; II) was examined. It was hypothesized that no significant effect modification would be observed between groups with and without symptoms. Similarly, the persistence of the association in the group classified as low to moderate risk of heart failure was explored, based on the WATCH-DM risk score.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
<p>A significant effect modification was defined as an interaction term with a p-value &lt; 0.05.</p>
</section>
<section id="multiple-imputed-by-chained-equations" class="level3" data-number="6.4.4">
<h3 data-number="6.4.4" class="anchored" data-anchor-id="multiple-imputed-by-chained-equations"><span class="header-section-number">6.4.4</span> Multiple imputed by chained equations</h3>
<p>Multiple Imputation by Chained Equations (MICE) was used to handle missing data. This procedure imputes missing values through an iterative series of predictive models, generating plausible estimates while preserving the relationships within the data. To avoid assigning the same confidence to an imputed values as to observed values, Rubin’s rules were followed. Rubin’s rules combine results from multiple imputed datasets by pooling estimates of interest (e.g., means or regression coefficients) using their within- and between-imputation variances.<span class="citation" data-cites="harel2018"><sup><a href="references.html#ref-harel2018" role="doc-biblioref">24</a></sup></span> This approach ensures valid statistical inferences by accounting for the uncertainty introduced by missing data.</p>
<p>In Study II, confounders were imputed to include as many participants as possible and to avoid excluding individuals with or without cardiovascular or mortality events. The dataset was imputed 10 times. In Study III, missing CARTs were imputed, as a proportion of participants had non-valid tests due to insufficient air in the Valsalva manoeuvre, unstable heartbeats, or data errors. These variables were used as auxiliary variables in the imputation to reduce bias.<span class="citation" data-cites="hughes2019"><sup><a href="references.html#ref-hughes2019" role="doc-biblioref">25</a></sup></span> All available variables on biochemical measures, diagnoses, medications, and causes of non-valid CARTs were used to impute each missing CART using predictive mean matching.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>
</section>
<section id="instrumental-bias" class="level3" data-number="6.4.5">
<h3 data-number="6.4.5" class="anchored" data-anchor-id="instrumental-bias"><span class="header-section-number">6.4.5</span> Instrumental bias</h3>
<p>In Studies I–III, physiological properties were investigated using dynamic measures and biomarkers to quantify autonomic function, arterial stiffness, and cardiac function. However, other conditions may affect the properties we are attempting to measure, resulting in instrumental bias.</p>
<p><em>Vascular Stiffness</em></p>
<p>In Study I, arterial stiffness was measured using cf-PWV and carotid distensibility. Both measures are influenced by arterial pressure at the time of examination. Arterial pressure affects the propagation of the pressure wave through the aorta (cf-PWV) and the expansion and contraction of the carotid artery (carotid distensibility).<span class="citation" data-cites="kim2007"><sup><a href="references.html#ref-kim2007" role="doc-biblioref">26</a></sup></span> To account for this, adjustments were made for MAP in the models.<span class="citation" data-cites="schaarup2024"><sup><a href="references.html#ref-schaarup2024" role="doc-biblioref">2</a></sup></span></p>
<p><em>Cardiovascular autonomic function</em></p>
<p>In Study II, autonomic function was assessed using multiday HRV recordings and hourly HRV measurements. Previous studies have shown that HRV is dependent on heart rate, and low HRV may simply reflect a higher resting heart rate (rHR). To adjust for this without overcorrecting for a collinear variable, HRV was pre-adjusted by regressing rHR on HRV, extracting the residuals, and using these as the pre-adjusted determinant. For hourly HRV, variability in heart rate may be influenced by changes in physical activity, creating a risk that HRV serves as a proxy for movement rather than autonomic function. To address this, a similar pre-adjustment approach was applied by regressing concurrent heart rate and physical acceleration to account for physical activity.<span class="citation" data-cites="schaarup2024b"><sup><a href="references.html#ref-schaarup2024b" role="doc-biblioref">14</a></sup></span></p>
<p><em>Biomarker of Heart Failure</em></p>
<p>In Study III, kidney function and overweight are known to influence NT-proBNP levels independently of heart failure.<span class="citation" data-cites="heidenreich2022"><sup><a href="references.html#ref-heidenreich2022" role="doc-biblioref">27</a></sup></span> Therefore, the model was adjusted to account for the confounding effect of eGFR on NT-proBNP levels in the analysis.<span class="citation" data-cites="schaarup2025"><sup><a href="references.html#ref-schaarup2025" role="doc-biblioref">16</a></sup></span></p>


<div id="refs" class="references csl-bib-body" role="list" style="display: none">
<div id="ref-schram2014" class="csl-entry" role="listitem">
<div class="csl-left-margin">1 </div><div class="csl-right-inline">Schram MT, Sep SJS, Kallen CJ van der, <em>et al.</em> <a href="https://doi.org/10.1007/s10654-014-9889-0">The maastricht study: An extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities</a>. <em>European Journal of Epidemiology</em> 2014; <strong>29</strong>: 439–51.</div>
</div>
<div id="ref-schaarup2024" class="csl-entry" role="listitem">
<div class="csl-left-margin">2 </div><div class="csl-right-inline">Schaarup J, Bjerg L, Hansen C, <em>et al.</em> Cardiovascular autonomic dysfunction is linked with arterial stiffness across glucose metabolism: The maastricht study. 2024 DOI:<a href="https://doi.org/10.1101/2024.12.03.24317865">10.1101/2024.12.03.24317865</a>.</div>
</div>
<div id="ref-christensen2004a" class="csl-entry" role="listitem">
<div class="csl-left-margin">3 </div><div class="csl-right-inline">Christensen JO, Sandbæk A, Lauritzen T, Borch-Johnsen K. <a href="https://doi.org/10.1007/s00125-004-1496-2">Population-based stepwise screening for unrecognised type&nbsp;2 diabetes is ineffective in general practice despite reliable algorithms</a>. <em>Diabetologia</em> 2004; <strong>47</strong>: 1566–73.</div>
</div>
<div id="ref-taskforceoftheeuropeansocietyofcardiologythenorthamericansocietyofpacingelectrophysiology1996" class="csl-entry" role="listitem">
<div class="csl-left-margin">4 </div><div class="csl-right-inline">Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology. <a href="https://doi.org/doi:10.1161/01.CIR.93.5.1043">Heart rate variability</a>. <em>Circulation</em> 1996; <strong>93</strong>: 1043–65.</div>
</div>
<div id="ref-umetani1998" class="csl-entry" role="listitem">
<div class="csl-left-margin">5 </div><div class="csl-right-inline">Umetani K, Singer DH, McCraty R, Atkinson M. <a href="https://doi.org/10.1016/S0735-1097(97)00554-8">Twenty-four hour time domain heart rate variability and heart rate: Relations to age and gender over nine decades</a>. <em>Journal of the American College of Cardiology</em> 1998; <strong>31</strong>: 593–601.</div>
</div>
<div id="ref-serrador1999" class="csl-entry" role="listitem">
<div class="csl-left-margin">6 </div><div class="csl-right-inline">Serrador JM, Finlayson HC, Hughson RL. <a href="https://doi.org/10.1136/hrt.82.6.e9">Physical activity is a major contributor to the ultra low frequency components of heart rate variability</a>. <em>Heart</em> 1999; <strong>82</strong>: e9.</div>
</div>
<div id="ref-akselrod1981" class="csl-entry" role="listitem">
<div class="csl-left-margin">7 </div><div class="csl-right-inline">Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. <a href="https://doi.org/10.1126/science.6166045">Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control</a>. <em>Science</em> 1981; <strong>213</strong>: 220–2.</div>
</div>
<div id="ref-taylor1998" class="csl-entry" role="listitem">
<div class="csl-left-margin">8 </div><div class="csl-right-inline">Taylor JA, Carr DL, Myers CW, Eckberg DL. <a href="https://doi.org/10.1161/01.CIR.98.6.547">Mechanisms underlying very-low-frequency RR-interval oscillations in humans</a>. <em>Circulation</em> 1998; <strong>98</strong>: 547–55.</div>
</div>
<div id="ref-jeffreyj.goldberger2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">9 </div><div class="csl-right-inline">Jeffrey J. Goldberger, Rishi Arora, Una Buckley, Kalyanam Shivkumar. <a href="https://doi.org/doi:10.1016/j.jacc.2018.12.064">Autonomic nervous system dysfunction</a>. <em>Journal of the American College of Cardiology</em> 2019; <strong>73</strong>: 1189–206.</div>
</div>
<div id="ref-mccraty2015" class="csl-entry" role="listitem">
<div class="csl-left-margin">10 </div><div class="csl-right-inline">Mccraty R, Shaffer F. <a href="https://doi.org/10.7453/gahmj.2014.073">Heart rate variability: New perspectives on physiological mechanisms, assessment of self-regulatory capacity, and health risk</a>. <em>Global Advances in Health and Medicine</em> 2015; <strong>4</strong>: 46–61.</div>
</div>
<div id="ref-elghozi1991" class="csl-entry" role="listitem">
<div class="csl-left-margin">11 </div><div class="csl-right-inline">Elghozi J-L, Laude D, Girard A. <a href="https://doi.org/10.1111/j.1440-1681.1991.tb01391.x">EFFECTS OF RESPIRATION ON BLOOD PRESSURE AND HEART RATE VARIABILITY IN HUMANS</a>. <em>Clinical and Experimental Pharmacology and Physiology</em> 1991; <strong>18</strong>: 735–42.</div>
</div>
<div id="ref-coopmans2020" class="csl-entry" role="listitem">
<div class="csl-left-margin">12 </div><div class="csl-right-inline">Coopmans C, Zhou TL, Henry RMA, <em>et al.</em> <a href="https://doi.org/10.2337/dc19-2367">Both prediabetes and type 2 diabetes are associated with lower heart rate variability: The maastricht study</a>. <em>Diabetes Care</em> 2020; <strong>43</strong>: 1126–33.</div>
</div>
<div id="ref-schaarup2024a" class="csl-entry" role="listitem">
<div class="csl-left-margin">13 </div><div class="csl-right-inline">Schaarup J. Actiheart validation of time-domain heart rate variability. 2024. <a href="https://figshare.com/articles/online_resource/Actiheart_validation_of_time-domain_heart_rate_variability/26182361">https://figshare.com/articles/online_resource/Actiheart_validation_of_time-domain_heart_rate_variability/26182361</a>.</div>
</div>
<div id="ref-schaarup2024b" class="csl-entry" role="listitem">
<div class="csl-left-margin">14 </div><div class="csl-right-inline">Schaarup JR, Bjerg L, Hansen CS, <em>et al.</em> <a href="https://doi.org/10.1101/2024.12.18.24319131">Cardiovascular autonomic dysfunction precedes cardiovascular disease and all-cause mortality: 11-year follow-up of the ADDITION-PRO study</a>. <em>medRxiv</em> 2024; : 2024.12.18.24319131.</div>
</div>
<div id="ref-hansen2025" class="csl-entry" role="listitem">
<div class="csl-left-margin">15 </div><div class="csl-right-inline">Hansen CS, Christensen MMB, Vistisen D, <em>et al.</em> <a href="https://doi.org/10.1007/s10286-024-01069-6">Normative data on measures of cardiovascular autonomic neuropathy and the effect of pretest conditions in a large danish non-diabetic CVD-free population from the lolland-falster health study</a>. <em>Clinical Autonomic Research</em> 2025; <strong>35</strong>: 101–13.</div>
</div>
<div id="ref-schaarup2025" class="csl-entry" role="listitem">
<div class="csl-left-margin">16 </div><div class="csl-right-inline">Schaarup JR, Bjerg L, Hansen CS, <em>et al.</em> Cardiovascular autonomic neuropathy and indices of heart failure in type 2 diabetes: The CANCAN study. <em>(unpublished)</em> 2025; published online June 25.</div>
</div>
<div id="ref-fleischer2011" class="csl-entry" role="listitem">
<div class="csl-left-margin">17 </div><div class="csl-right-inline">Fleischer J, Nielsen R, Laugesen E, Nygaard H, Poulsen PL, Ejskjaer N. <a href="https://doi.org/10.1177/193229681100500115">Self-monitoring of cardiac autonomic function at home is feasible.</a> <em>Journal of diabetes science and technology</em> 2011; <strong>5</strong>: 107–12.</div>
</div>
<div id="ref-tanlaizhou2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">18 </div><div class="csl-right-inline">Tan Lai Zhou, Ronald M. A. Henry, Coen D. A. Stehouwer, Thomas T. van Sloten, Koen D. Reesink, Abraham A. Kroon. <a href="https://doi.org/doi:10.1161/HYPERTENSIONAHA.118.11325">Blood pressure variability, arterial stiffness, and arterial remodeling</a>. <em>Hypertension</em> 2018; <strong>72</strong>: 1002–10.</div>
</div>
<div id="ref-willeit2016" class="csl-entry" role="listitem">
<div class="csl-left-margin">19 </div><div class="csl-right-inline">Willeit P, Kaptoge S, Welsh P, <em>et al.</em> <a href="https://doi.org/10.1016/S2213-8587(16)30196-6">Natriuretic peptides and integrated risk assessment for cardiovascular disease: An individual-participant-data meta-analysis</a>. <em>The Lancet Diabetes &amp; Endocrinology</em> 2016; <strong>4</strong>: 840–9.</div>
</div>
<div id="ref-segar2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">20 </div><div class="csl-right-inline">Segar MW, Patel KV, Hellkamp AS, <em>et al.</em> <a href="https://doi.org/10.1161/JAHA.121.024094">Validation of the WATCH<span>-</span>DM and TRS<span>-</span>HFDM risk scores to predict the risk of incident hospitalization for heart failure among adults with type 2 diabetes: A multicohort analysis</a>. <em>Journal of the American Heart Association</em> 2022; <strong>11</strong>: e024094.</div>
</div>
<div id="ref-segar2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">21 </div><div class="csl-right-inline">Segar MW, Vaduganathan M, Patel KV, <em>et al.</em> <a href="https://doi.org/10.2337/dc19-0587">Machine learning to predict the risk of incident heart failure hospitalization among patients with diabetes: The WATCH-DM risk score</a>. <em>Diabetes Care</em> 2019; <strong>42</strong>: 2298–306.</div>
</div>
<div id="ref-whoneed2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">22 </div><div class="csl-right-inline">Bendix Carstensen Steno Diabetes Center. Who needs the cox model anyway. <em>Stat Med</em> 2012; <strong>31</strong>: 10741088.</div>
</div>
<div id="ref-knol2012" class="csl-entry" role="listitem">
<div class="csl-left-margin">23 </div><div class="csl-right-inline">Knol MJ, VanderWeele TJ. <a href="https://doi.org/10.1093/ije/dyr218">Recommendations for presenting analyses of effect modification and interaction</a>. <em>International Journal of Epidemiology</em> 2012; <strong>41</strong>: 514–20.</div>
</div>
<div id="ref-harel2018" class="csl-entry" role="listitem">
<div class="csl-left-margin">24 </div><div class="csl-right-inline">Harel O, Mitchell EM, Perkins NJ, <em>et al.</em> <a href="https://doi.org/10.1093/aje/kwx349">Multiple imputation for incomplete data in epidemiologic studies</a>. <em>American Journal of Epidemiology</em> 2018; <strong>187</strong>: 576–84.</div>
</div>
<div id="ref-hughes2019" class="csl-entry" role="listitem">
<div class="csl-left-margin">25 </div><div class="csl-right-inline">Hughes RA, Heron J, Sterne JAC, Tilling K. <a href="https://doi.org/10.1093/ije/dyz032">Accounting for missing data in statistical analyses: Multiple imputation is not always the answer</a>. <em>International Journal of Epidemiology</em> 2019; <strong>48</strong>: 1294–304.</div>
</div>
<div id="ref-kim2007" class="csl-entry" role="listitem">
<div class="csl-left-margin">26 </div><div class="csl-right-inline">Kim EJ, Park CG, Park JS, <em>et al.</em> <a href="https://doi.org/10.1038/sj.jhh.1002120">Relationship between blood pressure parameters and pulse wave velocity in normotensive and hypertensive subjects: Invasive study</a>. <em>Journal of Human Hypertension</em> 2007; <strong>21</strong>: 141–8.</div>
</div>
<div id="ref-heidenreich2022" class="csl-entry" role="listitem">
<div class="csl-left-margin">27 </div><div class="csl-right-inline">Heidenreich PA, Bozkurt B, Aguilar D, <em>et al.</em> <a href="https://doi.org/10.1161/CIR.0000000000001063">2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines</a>. <em>Circulation</em> 2022; <strong>145</strong>: e895–1032.</div>
</div>
</div>
</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const isCodeAnnotation = (el) => {
    for (const clz of el.classList) {
      if (clz.startsWith('code-annotation-')) {                     
        return true;
      }
    }
    return false;
  }
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    text: function(trigger) {
      const codeEl = trigger.previousElementSibling.cloneNode(true);
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
      let selectedAnnoteEl;
      const selectorForAnnotation = ( cell, annotation) => {
        let cellAttr = 'data-code-cell="' + cell + '"';
        let lineAttr = 'data-code-annotation="' +  annotation + '"';
        const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
        return selector;
      }
      const selectCodeLines = (annoteEl) => {
        const doc = window.document;
        const targetCell = annoteEl.getAttribute("data-target-cell");
        const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
        const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
        const lines = annoteSpan.getAttribute("data-code-lines").split(",");
        const lineIds = lines.map((line) => {
          return targetCell + "-" + line;
        })
        let top = null;
        let height = null;
        let parent = null;
        if (lineIds.length > 0) {
            //compute the position of the single el (top and bottom and make a div)
            const el = window.document.getElementById(lineIds[0]);
            top = el.offsetTop;
            height = el.offsetHeight;
            parent = el.parentElement.parentElement;
          if (lineIds.length > 1) {
            const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
            const bottom = lastEl.offsetTop + lastEl.offsetHeight;
            height = bottom - top;
          }
          if (top !== null && height !== null && parent !== null) {
            // cook up a div (if necessary) and position it 
            let div = window.document.getElementById("code-annotation-line-highlight");
            if (div === null) {
              div = window.document.createElement("div");
              div.setAttribute("id", "code-annotation-line-highlight");
              div.style.position = 'absolute';
              parent.appendChild(div);
            }
            div.style.top = top - 2 + "px";
            div.style.height = height + 4 + "px";
            let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
            if (gutterDiv === null) {
              gutterDiv = window.document.createElement("div");
              gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
              gutterDiv.style.position = 'absolute';
              const codeCell = window.document.getElementById(targetCell);
              const gutter = codeCell.querySelector('.code-annotation-gutter');
              gutter.appendChild(gutterDiv);
            }
            gutterDiv.style.top = top - 2 + "px";
            gutterDiv.style.height = height + 4 + "px";
          }
          selectedAnnoteEl = annoteEl;
        }
      };
      const unselectCodeLines = () => {
        const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
        elementsIds.forEach((elId) => {
          const div = window.document.getElementById(elId);
          if (div) {
            div.remove();
          }
        });
        selectedAnnoteEl = undefined;
      };
      // Attach click handler to the DT
      const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
      for (const annoteDlNode of annoteDls) {
        annoteDlNode.addEventListener('click', (event) => {
          const clickedEl = event.target;
          if (clickedEl !== selectedAnnoteEl) {
            unselectCodeLines();
            const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
            if (activeEl) {
              activeEl.classList.remove('code-annotation-active');
            }
            selectCodeLines(clickedEl);
            clickedEl.classList.add('code-annotation-active');
          } else {
            // Unselect the line
            unselectCodeLines();
            clickedEl.classList.remove('code-annotation-active');
          }
        });
      }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./3-aim_hypothesis.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Aim and hypothesis</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./5-results.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">Results</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->



</body></html>